The market is driven by the increasing cost of medical treatment. In addition, the rising demand for training in and awareness of nutrigenomics technologies is anticipated to boost the growth of the nutrigenomics market.
The high prevalence of various diseases has a direct impact on healthcare costs, as patients spend heavily on treatment. The high cost of branded drugs further increases the burden. Hence, many people are opting for dietary supplements and fortified products that contain nutrients, such as vitamins, proteins, carotenoids, fibers, polyphenols, and probiotics, based on nutrigenomics. All these factors are driving the demand for nutrigenomics, thereby driving the growth of the market.
Vendor Landscape:
The global nutrigenomics market is fragmented market due to the presence of numerous established and emerging vendors, offering a wide range of nutrigenomic equipment used for nutrigenomic research and dietary products based on nutrigenomics. The leading vendors have the financial resources and technical expertise to carry out the R&D of advanced products. Also, they have strong brand recognition, established distribution networks, and an extensive product portfolio. Hence, small and medium-sized players find it difficult to compete with established players in terms of technological advances and access to distribution networks to expand their market presence. Thus, they adopt competitive pricing strategies to enhance their market penetration.
The following are identified as the major players in the market:
- BASF SE
- Cell Logic Pty Ltd
- Cura Integrative Medicine
- DNA Life
- Fagron NV
- geneOmbio Technologies Pvt Ltd.
- Genetic Healing
- Genova Diagnostics Inc.
- Greenarray
- Holistic Health International LLC
- Koninklijke DSM NV
- Metagenics Inc.
- My DNA Health Ltd.
- NutriFit Canada
- Nutrigenomix Inc.
- ORIG3N Inc.
- Preventine Life Care
- The Gene Box
- Xcode Life Sciences Pvt. Ltd
Nutrigenomics Market Application Outlook (Revenue, USD Million, 2021-2026)
- Obesity - size and forecast 2021-2026
- Cardiovascular diseases - size and forecast 2021-2026
- Cancer research - size and forecast 2021-2026
The market growth in the obesity segment will be significant over the forecast period. Nutrigenomics aids in increasing the understanding of how varying nutrition influences metabolic pathways and homeostatic control, which then can be used to prevent the development of chronic diet-related diseases such as obesity. This is the key factor driving the growth of the segment.
Nutrigenomics Market Geography Outlook (Revenue, USD Million, 2021-2026)
- North America - size and forecast 2021-2026
- Europe - size and forecast 2021-2026
- Asia - size and forecast 2021-2026
- Rest of World (ROW) - size and forecast 2021-2026
The market growth in North America will be significant during the forecast period. Governments in the region are making substantial investments in the field of molecular biology research. In addition, factors such as the increasing adoption of technologically advanced products by healthcare providers, a rise in healthcare expenditures, and growth in the number of advanced healthcare facilities in countries such as the US and Canada are contributing to the growth of the regional market.
Technavio's sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request Sample Report Here
Related Reports:
Nutrigenomics Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.4% |
Market growth 2022-2026 |
USD 690.14 million |
Market structure |
Fragmented |
YoY growth (%) |
11.8 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key consumer countries |
US, Canada, Germany, UK, and France |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
BASF SE, Cell Logic Pty Ltd, Cura Integrative Medicine, DNA Life, Fagron NV, geneOmbio Technologies Pvt Ltd., Genetic Healing, Genova Diagnostics Inc., Greenarray, Holistic Health International LLC, Koninklijke DSM NV, Metagenics Inc., My DNA Health Ltd., NutriFit Canada, Nutrigenomix Inc., ORIG3N Inc., Preventine Life Care, The Gene Box, and Xcode Life Sciences Pvt. Ltd |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Application
- 5.1 Market segments
- Exhibit 24: Chart on Application - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
- 5.2 Comparison by Application
- Exhibit 26: Chart on Comparison by Application
- Exhibit 27: Data Table on Comparison by Application
- 5.3 Obesity - Market size and forecast 2021-2026
- Exhibit 28: Chart on Obesity - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Obesity - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Obesity - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Obesity - Year-over-year growth 2021-2026 (%)
- 5.4 Cardiovascular diseases - Market size and forecast 2021-2026
- Exhibit 32: Chart on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
- 5.5 Cancer research - Market size and forecast 2021-2026
- Exhibit 36: Chart on Cancer research - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Cancer research - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Cancer research - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Cancer research - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by Application
- Exhibit 40: Market opportunity by Application ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 France - Market size and forecast 2021-2026
- Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 Cell Logic Pty Ltd
- Exhibit 89: Cell Logic Pty Ltd - Overview
- Exhibit 90: Cell Logic Pty Ltd - Product / Service
- Exhibit 91: Cell Logic Pty Ltd - Key offerings
- 10.4 Cura Integrative Medicine
- Exhibit 92: Cura Integrative Medicine - Overview
- Exhibit 93: Cura Integrative Medicine - Product / Service
- Exhibit 94: Cura Integrative Medicine - Key offerings
- 10.5 DNA Life
- Exhibit 95: DNA Life - Overview
- Exhibit 96: DNA Life - Product / Service
- Exhibit 97: DNA Life - Key offerings
- 10.6 Fagron NV
- Exhibit 98: Fagron NV - Overview
- Exhibit 99: Fagron NV - Business segments
- Exhibit 100: Fagron NV - Key news
- Exhibit 101: Fagron NV - Key offerings
- Exhibit 102: Fagron NV - Segment focus
- 10.7 Genova Diagnostics Inc.
- Exhibit 103: Genova Diagnostics Inc. - Overview
- Exhibit 104: Genova Diagnostics Inc. - Product / Service
- Exhibit 105: Genova Diagnostics Inc. - Key offerings
- 10.8 Holistic Health International LLC
- Exhibit 106: Holistic Health International LLC - Overview
- Exhibit 107: Holistic Health International LLC - Product / Service
- Exhibit 108: Holistic Health International LLC - Key offerings
- 10.9 Metagenics Inc.
- Exhibit 109: Metagenics Inc. - Overview
- Exhibit 110: Metagenics Inc. - Product / Service
- Exhibit 111: Metagenics Inc. - Key offerings
- 10.10 Nutrigenomix Inc.
- Exhibit 112: Nutrigenomix Inc. - Overview
- Exhibit 113: Nutrigenomix Inc. - Product / Service
- Exhibit 114: Nutrigenomix Inc. - Key offerings
- 10.11 The Gene Box
- Exhibit 115: The Gene Box - Overview
- Exhibit 116: The Gene Box - Product / Service
- Exhibit 117: The Gene Box - Key offerings
- 10.12 Xcode Life Sciences Pvt. Ltd
- Exhibit 118: Xcode Life Sciences Pvt. Ltd - Overview
- Exhibit 119: Xcode Life Sciences Pvt. Ltd - Product / Service
- Exhibit 120: Xcode Life Sciences Pvt. Ltd - Key offerings
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 121: Inclusions checklist
- Exhibit 122: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 123: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 124: Research methodology
- Exhibit 125: Validation techniques employed for market sizing
- Exhibit 126: Information sources
- 11.5 List of abbreviations
- Exhibit 127: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article